Combining treatment with myo-inositol and D -chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients

Nov 29, 2016

Authors: Giovanni Monastra, Vittorio Unfer, Abdel Halim Harrath & Mariano Bizzarri

Physiological Role and Clinical Utility of Inositols in Polycystic Ovary Syndrome

Nov 3, 2016

Authors: Arturo Bevilacqua, Mariano Bizzarri

Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate

Oct 4, 2016

Authors: Mariano Bizzarri, Simona Dinicola, Arturo Bevilacqua, and Alessandra Cucina

Pioglitazone Therapy Increases Insulin-Stimulated Release of d-Chiro-Inositol-Containing Inositolphosphoglycan Mediator in Women with Polycystic Ovary Syndrome

Oct 3, 2016

Authors: Anshu Gupta, Daniela Jakubowicz, and John E. Nestler

Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials

Sep 22, 2016

Authors: Vittorio Unfer, John E. Nestler, Zdravko A. Kamenov, Nikos Prapas, and Fabio Facchinetti

Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk

Sep 20, 2016

Authors: Rosa Lauretta, Giulia Lanzolla, Patrizia Vici, Luciano Mariani, Costanzo Moretti, and Marialuisa Appetecchia